View in EDS

170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors.

Saved in:
Bibliographic Details
Title: 170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors.
Authors: Jeger, S.1 (AUTHOR), Schönborn-Kellenberger, O.2 (AUTHOR), De Winter, H.1 (AUTHOR), Steeghs, N.3 (AUTHOR), Gort, E.4 (AUTHOR), Gomez-Roca, C.5 (AUTHOR), Stavropoulou, V.1 (AUTHOR), Kenefeck, R.1 (AUTHOR), Fernandez, E.1 (AUTHOR), Ji, H.1 (AUTHOR), Marchand, C.1 (AUTHOR), Legenne, P.1 (AUTHOR), Cassier, P.6 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1456-S1457. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 153829473
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Jeger%2C+S%2E%22">Jeger, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schönborn-Kellenberger%2C+O%2E%22">Schönborn-Kellenberger, O.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Winter%2C+H%2E%22">De Winter, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Steeghs%2C+N%2E%22">Steeghs, N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gort%2C+E%2E%22">Gort, E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2E%22">Gomez-Roca, C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stavropoulou%2C+V%2E%22">Stavropoulou, V.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kenefeck%2C+R%2E%22">Kenefeck, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fernandez%2C+E%2E%22">Fernandez, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ji%2C+H%2E%22">Ji, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marchand%2C+C%2E%22">Marchand, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Legenne%2C+P%2E%22">Legenne, P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cassier%2C+P%2E%22">Cassier, P.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 7, Vol. 32, pS1456-S1457. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=153829473
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.10.189
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S1456
    Titles:
      – TitleFull: 170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeger, S.
      – PersonEntity:
          Name:
            NameFull: Schönborn-Kellenberger, O.
      – PersonEntity:
          Name:
            NameFull: De Winter, H.
      – PersonEntity:
          Name:
            NameFull: Steeghs, N.
      – PersonEntity:
          Name:
            NameFull: Gort, E.
      – PersonEntity:
          Name:
            NameFull: Gomez-Roca, C.
      – PersonEntity:
          Name:
            NameFull: Stavropoulou, V.
      – PersonEntity:
          Name:
            NameFull: Kenefeck, R.
      – PersonEntity:
          Name:
            NameFull: Fernandez, E.
      – PersonEntity:
          Name:
            NameFull: Ji, H.
      – PersonEntity:
          Name:
            NameFull: Marchand, C.
      – PersonEntity:
          Name:
            NameFull: Legenne, P.
      – PersonEntity:
          Name:
            NameFull: Cassier, P.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2021 Supplement 7
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1